<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Accel-KKR on SoloSoft</title><link>https://www.solosoft.dev/tags/accel-kkr/</link><description>Recent content in Accel-KKR on SoloSoft</description><generator>Hugo</generator><language>en-us</language><atom:link href="https://www.solosoft.dev/tags/accel-kkr/index.xml" rel="self" type="application/rss+xml"/><item><title>ECRI Spins Off Supply Chain Business Staritas： A Key Turning Point for the MedTe</title><link>https://www.solosoft.dev/trends/2026-04-22-ecri-is-spinning-out-a-supply-chain-business/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.solosoft.dev/trends/2026-04-22-ecri-is-spinning-out-a-supply-chain-business/</guid><description>&lt;h2 id="why-is-a-medical-supply-chain-spin-off-becoming-a-focal-point-for-the-tech-industry"&gt;Why is a medical supply chain spin-off becoming a focal point for the tech industry?&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Simple answer: because it reveals the tipping point where a traditional, multi-billion-dollar medical logistics system is being fundamentally reshaped by data and AI.&lt;/strong&gt; When a nonprofit organization famous for publishing the &amp;ldquo;Top 10 Health Technology Hazards&amp;rdquo; decides to spin off its most profitable (or most promising) commercial unit and hand it over to a private equity firm skilled in tech scaling, that in itself is a manifesto about the industry&amp;rsquo;s next decade. We are not focusing on the transaction amount, but on its roadmap: the ECRI core will concentrate more on setting safety standards and resilience frameworks, while the independent Staritas, with capital backing, will fully sprint to transform these frameworks into scalable, AI-driven solutions. This is a perfect strategy of &amp;ldquo;separation of R&amp;amp;D and production&amp;rdquo; and &amp;ldquo;value release.&amp;rdquo;&lt;/p&gt;</description></item></channel></rss>